Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Core Study	STARTED	Placebo PBO/BMT	306
Core Study	STARTED	Brememlanotide BMT/BMT	308
Core Study	Received Intervention	Placebo PBO/BMT	303
Core Study	Received Intervention	Brememlanotide BMT/BMT	301
Core Study	COMPLETED	Placebo PBO/BMT	219
Core Study	COMPLETED	Brememlanotide BMT/BMT	173
Core Study	NOT COMPLETED	Placebo PBO/BMT	87
Core Study	NOT COMPLETED	Brememlanotide BMT/BMT	135
Open Label Extension	STARTED	Placebo PBO/BMT	191
Open Label Extension	STARTED	Brememlanotide BMT/BMT	130
Open Label Extension	COMPLETED	Placebo PBO/BMT	77
Open Label Extension	COMPLETED	Brememlanotide BMT/BMT	51
Open Label Extension	NOT COMPLETED	Placebo PBO/BMT	114
Open Label Extension	NOT COMPLETED	Brememlanotide BMT/BMT	79

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02338960/flow